Recent developments for Strive, Inc. include analyst coverage initiations with buy recommendations, insider buying reports, completion of the Semler Scientific acquisition, and market activity influenced by macroeconomic factors.

• B. Riley Securities initiated coverage of Strive Asset Management (ASST) with a buy recommendation on March 10, 2026 [N4].
• Strive announced the completion of the Semler Scientific acquisition on January 16, 2026, adding bitcoin reserves and a healthcare technology business [N6].
• Insider buying reports for ASST were noted on February 19, 2026, and January 14, 2026, indicating insider confidence [N5][N7].
• Maxim Group initiated coverage of Strive Asset Management (ASST) with a buy recommendation on December 10, 2025 [N8].
• Market conditions including higher bond yields and geopolitical tensions have influenced stock performance around March 2026 [N2][N1].

Strive's disciplined capital allocation using bitcoin as a hurdle rate aligns its investment strategy with a potentially appreciating digital asset, which may appeal to investors seeking exposure to bitcoin through a regulated, publicly traded vehicle. The company's innovative SATA Stock instrument and ATM program enable flexible capital raising to support bitcoin acquisitions. The acquisition of Semler Scientific adds a healthcare technology business with FDA-cleared products, potentially broadening revenue sources. Strong liquidity and a growing asset base provide the company with resources to execute its bitcoin treasury strategy and capitalize on market opportunities. Initiation of analyst coverage with buy recommendations and insider buying activity indicate positive market interest [N4][N6][N7][N8][S1].

Strive faces significant risks from the volatility and regulatory uncertainties inherent in bitcoin and digital assets, including cybersecurity threats, loss of private keys, and potential protocol changes. The company reported substantial net losses in 2025, driven by impairments and investment losses, which may pressure capital and investor confidence. Competition for capital with other bitcoin-related investment vehicles and service providers could affect financing costs and availability. The healthcare technology segment, while diversifying, faces challenges including reimbursement changes and market adoption risks. The company's innovative capital structure and perpetual preferred stock may introduce complexity and dilution risks. Overall, execution risks and market uncertainties could impact the company's financial performance and strategic objectives [S1].

Strive's moat is centered on its pioneering position as the first U.S. publicly traded bitcoin treasury asset management firm, combining structured finance expertise with a bitcoin-based reserve strategy. Its innovative capital structure, including the SATA Stock with an ATM program, provides a flexible and continuous capital formation mechanism. The company's diversified custody arrangements and rigorous security protocols for bitcoin holdings mitigate operational risks. Additionally, the acquisition of Semler Scientific adds a healthcare technology segment with patented and FDA-cleared products, diversifying revenue streams. The company's scale in bitcoin holdings and assets under management, along with its institutional-grade operational infrastructure, contribute to its competitive positioning in the emerging bitcoin treasury and asset management market [S1].

• Bitcoin and Digital Asset Risks: Strive's business is exposed to risks inherent in holding bitcoin, including cybersecurity threats, loss or theft of private keys, protocol design changes, governance disputes, and market volatility, which could adversely affect asset values and operations.
• Financial Performance and Capital Risks: The company reported significant net losses in 2025, including goodwill and intangible asset impairments, which may impact its ability to raise capital and sustain operations. Competition for capital with other bitcoin-related entities may increase financing costs.
• Regulatory and Market Risks: Evolving regulations around bitcoin and digital assets may affect Strive's operations and market access. The healthcare technology segment faces regulatory and reimbursement uncertainties that could impact product adoption and revenue.
• Operational and Execution Risks: Strive's innovative capital structure and perpetual preferred stock involve complexities that may affect investor perception and capital formation. Integration of acquisitions and execution of the bitcoin treasury strategy require effective management to mitigate risks.

• Strive, Inc. is a structured finance company and institutional asset manager focused on disciplined capital allocation and long-term value creation, using bitcoin as a hurdle rate for capital deployment to maximize long-term stockholder value and purchasing power [S1].
• Strive operates a bitcoin treasury strategy and is the first U.S. publicly traded bitcoin treasury asset management firm, managing over $2.4 billion in assets under management (AUM) as of December 31, 2025 [S1].
• The company generates recurring, fee-based revenue streams that increase with AUM, with plans to operate its asset-management segment within a single-digit-million dollar operating loss to profit range starting fiscal year 2026 [S1].
• Strive completed the acquisition of Semler Scientific in January 2026, acquiring Semler's bitcoin reserve and healthcare technology business, including the FDA-cleared QuantaFlo vascular testing product [S1][N6].
• Strive's bitcoin strategy includes acquiring bitcoin through open market purchases (beta initiatives) and strategic M&A or other transactions to acquire bitcoin at a discount (alpha strategies) [S1].
• In 2025, Strive acquired approximately 7,627 bitcoin at an aggregate cost of about $863 million, and from January to March 2026 acquired an additional 5,048 bitcoin through Semler Scientific acquisition plus 953 bitcoin purchased at an average price of about $81,092 per bitcoin [S1].
• As of December 31, 2025, Strive held digital assets valued at approximately $668.5 million, consisting of about 7,627 bitcoin, and cash and cash equivalents of $67.5 million, with total liquidity including cash and current assets significantly exceeding current liabilities [S1].
• Strive holds bitcoin in custodial accounts at U.S.-based institutional-grade custodians with strict security protocols, including cold storage and multi-factor authentication, and regularly reconciles holdings to the public blockchain [S1].
• Strive's subsidiary Semler Scientific markets QuantaFlo, a patented and FDA-cleared vascular testing product used in healthcare settings, primarily under a license model [S1].
• The company reported a net loss of $393.6 million for the fiscal year ended December 31, 2025, with basic and diluted earnings per share of -$9.04, reflecting significant non-cash impairments and investment losses related to digital assets [S1].
• Strive has a strong liquidity position as of December 31, 2025, with a current ratio of 6.66 and cash ratio of 6.26, supported by cash and cash equivalents of approximately $67.5 million and current assets of $71.8 million against current liabilities of $10.8 million [S1].
• Strive has developed a perpetual preferred equity instrument called SATA Stock, which incorporates an at-the-market (ATM) program to provide a flexible capital formation mechanism, with proceeds used to support bitcoin treasury strategy [S1].
• The company competes for capital with other bitcoin-related investment vehicles, miners, exchanges, and digital asset service providers, which may affect financing availability and costs [S1].
• Strive's bitcoin holdings are subject to risks inherent in digital assets, including cybersecurity threats, loss of private keys, protocol changes, and market volatility [S1].
• Recent news includes initiation of coverage with buy recommendations by B. Riley Securities and Maxim Group, insider buying reports, completion of Semler Scientific acquisition, and capital raising activities targeting bitcoin treasury expansion [N4][N6][N7][N8].